Hardback
Academic Entrepreneurship
Translating Discoveries to the Marketplace
9781785363436 Edward Elgar Publishing
Academic entrepreneurship is a multifactorial and multidimensional phenomenon. This book presents research featuring aspects of academic entrepreneurship at the regional, institutional, and organizational levels of analysis. Phillip H. Phan and the authors illustrate that the more interesting aspects of this subject are in the ‘tails of the distribution,’ where counter-intuitive findings from the data call simple theories into question and inspire a vigorous discussion of alternatives.
More Information
Critical Acclaim
Contributors
Contents
More Information
Academic entrepreneurship is a multifactorial and multidimensional phenomenon. This book presents research featuring aspects of academic entrepreneurship at the regional, institutional, and organizational levels of analysis. Phillip H. Phan and the authors illustrate that the more interesting aspects of this subject are in the ‘tails of the distribution,’ where counter-intuitive findings from the data call simple theories into question and inspire a vigorous discussion of alternatives.
This edited collection covers a variety of topics including, but not limited to:
• corporate governance of innovation
• technology commercialization in pharmaceuticals and life sciences
• institutional impediments to technology development and economic growth
• economic impact of universities
• academic labor markets and technology commercialization
• translational research and development
• technology commercialization in regenerative medicine.
The contributors also consider the relative value of general versus specific human capital development and the implications for entrepreneurship and wealth creation.
The audience for this book comprises PhD students, new scholars in technology commercialization research, university technology transfer office personnel, economic development specialists and policymakers, and students studying the management of technology.
This edited collection covers a variety of topics including, but not limited to:
• corporate governance of innovation
• technology commercialization in pharmaceuticals and life sciences
• institutional impediments to technology development and economic growth
• economic impact of universities
• academic labor markets and technology commercialization
• translational research and development
• technology commercialization in regenerative medicine.
The contributors also consider the relative value of general versus specific human capital development and the implications for entrepreneurship and wealth creation.
The audience for this book comprises PhD students, new scholars in technology commercialization research, university technology transfer office personnel, economic development specialists and policymakers, and students studying the management of technology.
Critical Acclaim
''Professor Phan has assembled an impressive interdisciplinary set of scholars who present important evidence on academic entrepreneurship, with a strong emphasis on the life sciences. This is a lucid and insightful volume. It represents an important milestone in the study of the translation of discoveries to the marketplace, providing important theoretical and empirical perspectives on what’s been learned, what the evidence means to academics, policymakers, and practitioners, and future directions for research. A must-read and a critical reference tool for anyone interested in academic entrepreneurship.''
– Donald Siegel, University at Albany, State University of New York, US
– Donald Siegel, University at Albany, State University of New York, US
Contributors
Contributors: D. Balkin, S. Berry, A.J. Bock, B. Bradley, R. Cawley, B. Chatot, J.A. Cunningham, S. Deely, J. DeFelice, I. Dibua, D. Ding, G.R. Djavanshir, A. Dobos, M. Duffy, H. Ener, M. Guerrero, K. Hazelbach, W. Hefley, H. Hoang, H. Hu, D. Johnson, M. Kearns, M. Kiniry, B.K. Lee, K.T. Lim, R. Magath, G. Markman, M. Meoli, M. Michaels, S. Paruchuri, P.H. Phan, A. Rosenbaum, C. Rosenfeld, S.Y.Sohn, J. Somma, R. Strouse, D. Urbano, Z. Venema, S. Vismara, C. Weber, J. Yang
Contents
Contents:
Introduction
Phillip H. Phan
1. Translating Smart Kitchen Technologies from the Lab to the Home
Bill Hefley, Dan Ding, Aimee Rosenbaum, Megan Kiniry, Jason Somma, Skyler Berry, Katelyn Hazelbach, Matthew Michaels, James DeFelice, Meghan Duffy, Meredith Kearns, Ryan Magath, Jingzi Yang, Rachel Cawley, Brian Chatot, Samuel Deely, Bryan Bradley, Allison Dobos, Callie Rosenfeld, Rebekah Strouse, Ihinosen Dibua, Haoran Hu, Zachary Venema and Carolyn Weber
PART 1 DRIVERS OF ENTREPRENEURIAL ACTIVITY
2. Poor Opportunities in the Academic Labor Market as a Cause of Spin-Offs
Silvio Vismara and Michele Meoli
PART II ORGANIZING FOR COMMERCIALIZATION IN THE BIOPHARMACEUTICAL INDUSTRY
3. When do Biotechnology Ventures Pursue International R&D Alliances?
Hakan Ener and Ha Hoang
4. A Technology Credit Scoring Model for the Biotechnology Industry?
So Young Sohn, Kyong Taek Lim and Bo Kyeong Lee
5. The Dynamics of R&D Inertia in the Pharmaceutical Chemicals Industry
Srikanth Paruchuri
6. How Corporate Governance Affects Innovation in the Pharmaceutical Industry
Phillip H. Phan, Gideon Markman and David Balkin
PART III INSTITUTIONAL CAUSES AND POLICY CONSEQUENCES OF TECHNOLOGY ENTREPRENEURSHIP
7. The Institutional Inertias that Constrain Technology-Driven Economic Development
G. Reza Djavanshir
8. The Economic Impact of Public Universities in the United Kingdom
Maribel Guerrero, David Urbano and James A. Cunningham
9. A Comparative Study of Ecosystem Development in Regenerative Medicine
Adam J. Bock and David Johnson
Conclusion: Directions for Future Research
Phillip H. Phan
Index
Introduction
Phillip H. Phan
1. Translating Smart Kitchen Technologies from the Lab to the Home
Bill Hefley, Dan Ding, Aimee Rosenbaum, Megan Kiniry, Jason Somma, Skyler Berry, Katelyn Hazelbach, Matthew Michaels, James DeFelice, Meghan Duffy, Meredith Kearns, Ryan Magath, Jingzi Yang, Rachel Cawley, Brian Chatot, Samuel Deely, Bryan Bradley, Allison Dobos, Callie Rosenfeld, Rebekah Strouse, Ihinosen Dibua, Haoran Hu, Zachary Venema and Carolyn Weber
PART 1 DRIVERS OF ENTREPRENEURIAL ACTIVITY
2. Poor Opportunities in the Academic Labor Market as a Cause of Spin-Offs
Silvio Vismara and Michele Meoli
PART II ORGANIZING FOR COMMERCIALIZATION IN THE BIOPHARMACEUTICAL INDUSTRY
3. When do Biotechnology Ventures Pursue International R&D Alliances?
Hakan Ener and Ha Hoang
4. A Technology Credit Scoring Model for the Biotechnology Industry?
So Young Sohn, Kyong Taek Lim and Bo Kyeong Lee
5. The Dynamics of R&D Inertia in the Pharmaceutical Chemicals Industry
Srikanth Paruchuri
6. How Corporate Governance Affects Innovation in the Pharmaceutical Industry
Phillip H. Phan, Gideon Markman and David Balkin
PART III INSTITUTIONAL CAUSES AND POLICY CONSEQUENCES OF TECHNOLOGY ENTREPRENEURSHIP
7. The Institutional Inertias that Constrain Technology-Driven Economic Development
G. Reza Djavanshir
8. The Economic Impact of Public Universities in the United Kingdom
Maribel Guerrero, David Urbano and James A. Cunningham
9. A Comparative Study of Ecosystem Development in Regenerative Medicine
Adam J. Bock and David Johnson
Conclusion: Directions for Future Research
Phillip H. Phan
Index
